Immunotherapy and Targeted Therapy Regimens for Melanoma Immunotherapy and Targeted Therapy Regimens for Melanoma
Dr Jeffrey Weber discusses recent abstracts focused on melanoma, as presented at ESMO.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

ESMO : Breakthroughs in Melanoma Treatment Regimens ESMO : Breakthroughs in Melanoma Treatment Regimens
Dr Jeffrey Weber discusses recent abstracts focused on melanoma, as presented at ESMO.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Science Fiction Becomes Fact: Neoantigen Therapy in Melanoma Science Fiction Becomes Fact: Neoantigen Therapy in Melanoma
Prof David Kerr discusses neoantigen therapy for patients with melanoma. (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Medicare IHC Claims With Melanoma Dxs Increased, Study Finds Medicare IHC Claims With Melanoma Dxs Increased, Study Finds
With sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2024 Category: Cancer & Oncology Tags: Dermatology Source Type: news

Rate of Malignancy Low in Pediatric LM Rate of Malignancy Low in Pediatric LM
Pediatric longitudinal melanonychia may look like subungual melanoma in adults, but a low probability of malignancy makes clinical monitoring a reasonable noninvasive management strategy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 1, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news

Ninja, Video Gaming Star on Twitch, Reveals Skin Cancer Diagnosis
Tyler Blevins, the video game superstar known as Ninja, revealed this week that he had been diagnosed with melanoma, a form of skin cancer. Mr. Blevins, 32, said on social media on Tuesday that a mole was removed from his foot during an annual checkup with a dermatologist a few weeks ago. “It came…#tylerblevins #ninja (Source: Reuters: Health)
Source: Reuters: Health - March 27, 2024 Category: Consumer Health News Source Type: news

Ninja, Twitch ’s Top Streamer, Reveals Skin Cancer Diagnosis
The gamer, Tyler Blevins, said a mole removed from his foot during a recent checkup with a dermatologist was found to be a melanoma. (Source: NYT Health)
Source: NYT Health - March 27, 2024 Category: Consumer Health News Authors: Johnny Diaz Tags: Blevins, Tyler (1991- ) Skin Cancer Melanomas Computer and Video Games Youth American Cancer Society Source Type: news

Antidote and Melanoma Research Alliance join forces to enhance clinical trial search for people impacted by melanoma
The collaboration introduces an improved patient and caregiver experience to facilitate more accurate matches to appropriate clinical trials for individuals affected by melanoma. MIAMI and WASHINGTON, March 26, 2024 /PRNewswire-PRWeb/ -- Antidote Technologies ("Antidote"), a... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 26, 2024 Category: Pharmaceuticals Source Type: news

Military Service Can Bring Melanoma Danger
TUESDAY, March 12, 2024 — U.S. military veterans, especially those who served in the Air Force, are at high risk for one of the deadliest skin cancers, melanoma.The risk owes to work hazards associated with service in countries near the equator... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 12, 2024 Category: General Medicine Source Type: news

TIL for Melanoma: What Are the Costs and Challenges? TIL for Melanoma: What Are the Costs and Challenges?
A new FDA-approved treatment for melanoma has hit the market with a high price, and clinicians are working with insurers to determine out-of-pocket costs for patients.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Does breast radiation therapy raise risk of skin cancer?
Radiation therapy for breast cancer treatment leads to an increased risk of skin cancer, according to research published March 8 in JAMA Network Open. A team led by Shawheen Rezaei from Stanford University found that the risk of non-keratinocyte skin cancer diagnosis such as melanoma and hemangiosarcoma after breast cancer treatment with radiation was more than 50% higher. “Although occurrences of non-keratinocyte skin cancers are rare, physicians should be aware of this elevated risk to help inform follow-up care,” the Rezaei team wrote. While breast cancer treatment strategies have improved over the decades, survi...
Source: AuntMinnie.com Headlines - March 11, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Breast Imaging Source Type: news

New NCCN Melanoma Guidelines Capture Evolving Best Practice New NCCN Melanoma Guidelines Capture Evolving Best Practice
NCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 9, 2024 Category: Internal Medicine Tags: Dermatology Source Type: news

BAMF Health to partner with Corewell Health
BAMF Health and Corewell Health Haworth Innovative Therapeutics Clinic plan to collaborate on a clinical trial to test targeted radiation therapy for cancer patients. The phase I trial is sponsored by Y-mAbs Therapeutics and will include both adolescent and adult patients with recurrent or resistant small-cell lung cancer, sarcoma, and malignant melanoma. Trial participants will receive tumor-targeting treatment with an antibody that binds to a protein called GD-2 on the surface of the cancer cells, then a radioisotope infusion that binds to the antibody and delivers the radiation to cancer cells, BAMF Health said. (Sourc...
Source: AuntMinnie.com Headlines - March 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Newly Approved Cell Therapy For Advanced Melanoma, Amtagvi, Is A Potential Breakthrough
A confirmatory Phase 3 trial is ongoing to verify Amtagvi ’s clinical benefit in advanced melanoma patients. If confirmed, Amtagvi will be an important breakthrough. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 4, 2024 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news

Kimmtrak Tebentafusp Sales Increase By 64% In 2023
In the battle against melanoma, Kimmtrak has emerged as a groundbreaking treatment that offers an innovative approach of treatment with significant commercial potential. Although Kimmtrak is currently only approved for the treatment of uveal melanoma, clinical trials are being conducted to…#tebentafusp #immunocore (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news